← Back to Search

Behavioral Intervention

Fatigue Management Programs for Multiple Sclerosis

N/A
Waitlist Available
Led By Matthew Plow, PhD
Research Sponsored by Case Western Reserve University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age ≥ 18 years
Self-report diagnosis of MS
Timeline
Screening 3 weeks
Treatment Varies
Follow Up each patient will be given the assessments at 4 points during the study, at baseline, 8 weeks, 3 months, and 6 months
Awards & highlights

Study Summary

This trial is comparing 3 ways of delivering a course on reducing fatigue for people with MS. The goal is to see if the cheaper and easier versions are just as good as the in-person version.

Who is the study for?
This trial is for adults over 18 with multiple sclerosis (MS) who feel very tired and can speak English. They must be able to give consent, have internet access for online sessions or travel ability for in-person sessions.Check my eligibility
What is being tested?
The study compares three ways of delivering a fatigue management course: via the internet, teleconference, and one-on-one in person. It aims to see if the first two methods are just as good as personal meetings at reducing MS-related fatigue and improving life quality.See study design
What are the potential side effects?
Since this trial involves non-medical interventions like educational courses delivered through various communication methods, there are no direct medical side effects associated with drugs or procedures.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I have been diagnosed with multiple sclerosis.
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~each patient will be given the assessments at 4 points during the study, at baseline, 8 weeks, 3 months, and 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and each patient will be given the assessments at 4 points during the study, at baseline, 8 weeks, 3 months, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change from Baseline in fatigue levels
Secondary outcome measures
Change from Baseline in quality of life will be assessed

Trial Design

3Treatment groups
Active Control
Group I: InternetActive Control1 Intervention
Internet Intervention arm
Group II: TeleconferenceActive Control1 Intervention
Teleconference Intervention arm
Group III: I-to-1, in-personActive Control1 Intervention
1-to-1, in-person intervention arm

Find a Location

Who is running the clinical trial?

University of MinnesotaOTHER
1,372 Previous Clinical Trials
1,587,604 Total Patients Enrolled
5 Trials studying Multiple Sclerosis
355 Patients Enrolled for Multiple Sclerosis
Queen's University, Kingston, OntarioOTHER
7 Previous Clinical Trials
82,830 Total Patients Enrolled
The Cleveland ClinicOTHER
1,023 Previous Clinical Trials
1,365,248 Total Patients Enrolled
19 Trials studying Multiple Sclerosis
3,566 Patients Enrolled for Multiple Sclerosis

Media Library

Managing Fatigue course - 1-to-1, in-person (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT03550170 — N/A
Multiple Sclerosis Research Study Groups: Internet, Teleconference, I-to-1, in-person
Multiple Sclerosis Clinical Trial 2023: Managing Fatigue course - 1-to-1, in-person Highlights & Side Effects. Trial Name: NCT03550170 — N/A
Managing Fatigue course - 1-to-1, in-person (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03550170 — N/A
Multiple Sclerosis Patient Testimony for trial: Trial Name: NCT03550170 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the overall size of the participating cohort in this exploration?

"To successfully perform this trial, 582 volunteers who meet the pre-defined selection criteria are necessary. These people can be recruited from Case Western Reserve University in Cleveland, Ohio and University of Minnesota in Minneapolis, Minnesota."

Answered by AI

Are there any slots left in the trial for participants?

"Affirmative. According to clinicaltrials.gov, recruiting for this scientific trial is ongoing and began on March 1st 2019 with its most recent adjustment taking place December 16th 2021. A total of 582 participants are sought from 3 different locations."

Answered by AI

Who else is applying?

What state do they live in?
Tennessee
What site did they apply to?
University of Illinois at Chicago
University of Minnesota
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
3+

Why did patients apply to this trial?

I have severe fatigue with MS. I would like to try new treatment to see if it works.
PatientReceived 1 prior treatment
Fatigue is always been. My major symptom with my MS. I have tried two different drugs. Currently, I am not on either of them, but I am getting B12 shots.
PatientReceived 1 prior treatment

What questions have other patients asked about this trial?

Do you pay for time and Travel?
PatientReceived 2+ prior treatments
~96 spots leftby Apr 2025